newsfilter
← Latest News
Business Wire·

Zura Bio Announces Participation in June Investor Conferences

Zura Bio Limited (NASDAQ:ZURA) ("Zura Bio"), a clinical-stage immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases, today announced that members of senior management will